REVISTA ESPAÑOLA DE
CARDIOLOGÍA
ISSN: 1885-5857 Impact factor 2023 7.2
Vol. 77. Num. 4.
Pages 356 (April 2024)

Letter to the editor
Risk of ticagrelor versus clopidogrel discontinuation

Riesgo de interrupción del ticagrelor frente al clopidogrel

Manuel Martínez-Sellésab
Nonadherence to ticagrelor versus clopidogrel and clinical outcomes in patients with ACS. Results from the CREA-ARIAM registry
Rev Esp Cardiol. 2024;77:113-2410.1016/j.rec.2023.05.011
Manuel Almendro-Delia, Gloria Padilla-Rodríguez, Begoña Hernández-Meneses, Emilia Blanco-Ponce, José A. Arboleda-Sánchez, Juan Carlos Rodríguez-Yáñez, José Manuel Soto-Blanco, Isabel Fernández-García, José M. Castillo-Caballero, Juan C. García-Rubira, Rafael Hidalgo-Urbano
Risk of ticagrelor versus clopidogrel discontinuation. Response
Rev Esp Cardiol. 2024;77:356-710.1016/j.rec.2023.11.015
Manuel Almendro-Delia, Juan C. García-Rubira, Rafael Hidalgo-Urbano
https://doi.org/10.1016/j.rec.2023.11.018
View PDF
Lea este artículo en español
Share

Options

Identify yourself

Not yet a subscriber to the journal?

Revista Española de Cardiología (English Edition)
Subscribe to the journal

Purchase access to the article

By purchasing the article, the PDF of the same can be downloaded

Price: 19,34 €

Phone for incidents

Monday to Friday from 9am to 6pm (GMT+1) except for the months of July and August, which will be from 9am to 3pm

Calls from Spain 932 415 960
Calls from outside Spain +34 932 415 960

E-mail

atencionalcliente@elsevier.com
Copyright © 2023. Sociedad Española de Cardiología
Are you a healthcare professional authorized to prescribe or dispense medications?